Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Kodiak Sciences Inc. Logo
Clinical-stage biopharma developing therapeutics for chronic retinal diseases.
United States of America
KOD
Kohjin Bio Co., Ltd. Logo
Develops and sells culture media, biological materials, and diagnostics for research.
Japan
177A
KOLON LIFE SCIENCE Inc. Logo
Develops cell/gene therapies and manufactures APIs and specialty chemicals.
South Korea
102940
Kolon TissueGene, Inc. Logo
A clinical-stage biopharma developing cell and gene therapies for orthopedic diseases.
United States of America
950160
Biopharmaceutical company developing products for animal and human health.
South Korea
041960
KOREA ARLICO PHARM CO.,LTD. Logo
Develops, manufactures, and sells generic and other pharmaceutical products.
South Korea
260660
Develops, manufactures, and markets pharmaceuticals and other healthcare products.
South Korea
014570
Develops and produces prescription medicines with a focus on Central Nervous System drugs.
South Korea
032300
KOREA UNITED PHARM INC Logo
Pharmaceutical firm developing and manufacturing drugs for global export.
South Korea
033270
Korro Bio, Inc. Logo
Develops precision genetic medicines that utilize the body's natural RNA editing process.
United States of America
KRRO

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.